Seres Therapeutics Quote, Financials, Valuation and Earnings

Seres Therapeutics Price Quote

+0.16 (+2.91%)
(Updated: February 2, 2023 at 7:50 PM ET)

Seres Therapeutics Key Stats

Seres Therapeutics (MCRB) is a Sell

Day range:
$5.36 - $5.57
52-week range:
$2.50 - $9.49
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Seres Therapeutics Make?

Is Seres Therapeutics Growing As A Company?

  • What Is Seres Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.77%
  • What Is Seres Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Seres Therapeutics Stock Price Performance

What Is Seres Therapeutics 52-Week High & Low?

Seres Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Seres Therapeutics?

  • How Much Debt Does Seres Therapeutics Have?
    Total long term debt quarterly is $50.6M
  • How Much Cash Does Seres Therapeutics Have?
    Cash and short term investments quarterly total is $195.8M
  • What Is Seres Therapeutics’s Book Value Per Share?
    Book value per share is 0.25

Is Seres Therapeutics Cash Flow Positive?

  • What Is MCRB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$40.5M
  • What Is Seres Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $26.8M
  • What Is Seres Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $74.7M

Seres Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    MCRB return on invested capital is -74.87%
  • What Is Seres Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -31.96%
  • What Is MCRB Return On Equity?
    ROE is a measure of profitability and is -100.66%

Seres Therapeutics Earnings Date & Stock Price

Seres Therapeutics Competitors

  • Who Are Seres Therapeutics's Competitors?
    Below is a list of companies who compete with Seres Therapeutics or are related in some way:
    • Design Therapeutics Inc (DSGN)
    • Inhibrx Inc (INBX)
    • Protagonist Therapeutics Inc (PTGX)
    • scPharmaceuticals Inc (SCPH)
    • Stoke Therapeutics Inc (STOK)

Seres Therapeutics Dividend Yield

Data Unavailable

Seres Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.81%
Revenue: -76.9% -50.87%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 13.43
Upside from Last Price: 144.6%

Major Shareholders

  • How many MCRB shares are owned by institutional investors?
    217.6M MCRB shares are owned by institutional investors
  • How many MCRB shares are owned by insiders?
    1.2M MCRB shares are owned by insiders